New Perspectives and Future Challenges in Diabetic Retinopathy
A special issue of Diabetology (ISSN 2673-4540).
Deadline for manuscript submissions: 20 June 2026 | Viewed by 540
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, "New Perspectives and Future Challenges in Diabetic Retinopathy", aims to explore the cutting edge of research into this sight-threatening complication of diabetes. Diabetic retinopathy remains a leading cause of blindness, and a deeper understanding of its complex pathophysiology is paramount for developing more effective treatments. We welcome contributions that unveil novel mechanistic insights into its development and progression, identify promising new therapeutic target molecules, and showcase innovative strategies for drug delivery to the retina. This includes, but is not limited to, advancements in areas such as ophthalmic formulations designed to enhance therapeutic efficacy and improve patient compliance through non-invasive routes. By bringing together diverse, cutting-edge perspectives, we hope to illuminate current hurdles and pave the way for future breakthroughs that will ultimately improve patient outcomes and preserve vision. We eagerly anticipate your valuable contributions to this rapidly evolving field.
Prof. Dr. Akifumi Kushiyama
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetic retinopathy
- novel pathophysiology
- therapeutic targets
- drug delivery systems
- future therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
